- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03644433
Impact of Uterine Closure Techniques on the Cesarean Scar Thickness After Repeated Cesarean Section
August 23, 2018 updated by: Ragıp Atakan Al, Ataturk University
Impact of Single Layer Versus Double Layer Uterine Closure on the Cesarean Scar Healing
We compares two techniques of uterine closure on myometrium thickness at the site of uterine scar of women who underwent repeated cesarean section.
We will evaluate myometrial thickness by transvaginal ultrasound six months after cesarean.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Raşit Özler, Md
- Phone Number: 00905465252595
- Email: m.rasitozler@gmail.com
Study Contact Backup
- Name: ragıp a al, md
- Phone Number: 00904423447649
- Email: atakanal@gmail.com
Study Locations
-
-
-
Erzurum, Turkey, 25240
- Recruiting
- Atatürk Üniversitesi Araştırma Hastanesi
-
Contact:
- Raşit Özler, Md
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- previous two or three cesarean
- gestational weeks >=36 weeks
Exclusion Criteria:
- risk of obstetric haemorrhage
- suspicion or diagnosis placenta previa or accrete syndrome
- chorioamnionitis
- uterine myoma in the anterior uterine segment
- hysterotomy other than lower segment uterine incision at previous cesarean
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Single layer
Single layer closure
|
Uterine incision will be approximated with continuous unlocked suture avoiding the inclusion endometrium and without trimming incision edges.
|
Active Comparator: Double layer with resection
Double layer closure after resection uterine scar
|
Uterine incision will be trimmed and old scar tissue will be removed.
Then first, endometrium will be approximated by continuous unlocked suture mimicking subcuticular suture avoiding the inclusion of endometrium and second, upper part of myometrium will be approximated by a continuous unlocked suture.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
residual myometrial thickness
Time Frame: 6 months after cesarean
|
Myometrial thickness at the uterine scar by transvaginal ultrasound
|
6 months after cesarean
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in hemoglobin
Time Frame: 48 hours after cesarean
|
Difference in haemoglobin measured preoperatively and postoperatively 48 hours
|
48 hours after cesarean
|
Length of hospitalization
Time Frame: One month after cesarean
|
Duration in days
|
One month after cesarean
|
residual myometrial thickness
Time Frame: 6 weeks after cesarean
|
Myometrial thickness at the uterine scar by transvaginal ultrasound
|
6 weeks after cesarean
|
Healing ratio
Time Frame: 6 months after cesarean
|
residual myometrial thickness * 100 /total myometrial thickness above uterine scar
|
6 months after cesarean
|
Healing ratio
Time Frame: 6 weeks after cesarean
|
residual myometrial thickness * 100 /total myometrial thickness above uterine scar
|
6 weeks after cesarean
|
Existence of cesarean scar defect
Time Frame: 6 months after cesarean
|
The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm.
|
6 months after cesarean
|
Existence of cesarean scar defect
Time Frame: 6 weeks after cesarean
|
The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 1 mm.
|
6 weeks after cesarean
|
Operation time
Time Frame: 10 minute after cesarean completed
|
skin-to-skin operation time
|
10 minute after cesarean completed
|
Blood product transfusion
Time Frame: One week after cesarean
|
unite number of transfused packed erythrocyte
|
One week after cesarean
|
Maternal infectious morbidity
Time Frame: six weeks after cesarean
|
prevalence of postpartum endometritis, skin wound dehiscence and post operative fever.
|
six weeks after cesarean
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 23, 2018
Primary Completion (Anticipated)
April 30, 2019
Study Completion (Anticipated)
April 30, 2019
Study Registration Dates
First Submitted
July 6, 2018
First Submitted That Met QC Criteria
August 21, 2018
First Posted (Actual)
August 23, 2018
Study Record Updates
Last Update Posted (Actual)
August 24, 2018
Last Update Submitted That Met QC Criteria
August 23, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- B.30.2.ATA.0.01.00/4
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Complications
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
University of CalgaryNot yet recruitingCesarean Section ComplicationsCanada
-
Peking University People's HospitalNot yet recruiting
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt
-
Gaziosmanpasa Research and Education HospitalUnknownCesarean Section ComplicationsTurkey
-
Ain Shams UniversityUnknownCesarean Section ComplicationsEgypt
-
Mohamed Abdelrady MohamedCompletedCesarean Section ComplicationsEgypt
-
McGill University Health Centre/Research Institute...Thammasat UniversityUnknownCesarean Section ComplicationsCanada
-
Cairo UniversityUnknownCesarean Section ComplicationsEgypt
Clinical Trials on Single layer closure
-
Ataturk UniversityCompletedCesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Abouqir General HospitalAlexandria UniversityCompletedSurgical Wound Closure TechniqueEgypt
-
Tokat Gaziosmanpasa UniversityCompletedCesarean Section Complications | IsthmoceleTurkey
-
Korea University Guro HospitalJohnson and Johnson Medical Korea LtdNot yet recruitingScar Quality Assessment and Safety
-
Tanta UniversityRecruitingVentral Hernia | Incisional Hernia | Abdominal Wall WoundEgypt
-
Austrian Research Group for Regenerative and Orthopedic...UnknownRotator Cuff TearAustria
-
University of Texas Southwestern Medical CenterActive, not recruitingSurgical IncisionUnited States
-
Yale UniversityCompletedMyometrial RemodelingUnited States
-
Zealand University HospitalRegion ZealandCompleted